Ossur Hf : Share buy-back of 2,465,000 own shares for approx. USD 8 million
Announcement from Össur hf. No. 47/2015
Reykjavík, 6 November 2015
Share buy-back of 2,465,000 own shares for approx. USD 8 million
Reference is made to Össur hf.'s announcement No. 46/2015 published on 28 October 2015.
Today the Company purchased 2,465,000 own shares (approx. 0.6% of the Company's total share capital) on NASDAQ Copenhagen at the price of DKK 22,2 per share. The total purchase amount was DKK 54,723,000 million or approx. USD 8 million.
The purpose of the share buy-back is to adjust the capital structure by distributing capital to shareholders in line with the Company's Capital Structure and Dividend Policy. A proposal to decrease the share capital will be submitted to the Annual General Meeting in 2016 as a result of this transaction.
Jón Sigurðsson, President & CEO Tel: +354 515 1300
Sveinn Sölvason, CFO Tel: +354 515 1300
Össur press releases by e-mail
If you wish to receive Össur press releases by e-mail please register at the following web-site: http://www.ossur.com/investormailings
Össur (NASDAQ: OSSR) is a global leader in non-invasive orthopaedics that help people live a life without limitations. Its business is focused on improving people's mobility through the delivery of innovative technologies within the fields of braces, supports and prosthetic limbs. A recognized "Technology Pioneer", Össur invests significantly in research and product development; its award-winning designs ensuring a consistently strong position in the market. Successful patient and clinical outcomes are further empowered via Össur's educational programs and business solutions. Headquartered in Iceland, Össur has major operations in the Americas, Europe and Asia, with additional distributors worldwide. www.ossur.com
This press release includes "forward-looking statements" which involve risks and uncertainties that could cause actual results to differ materially from results expressed or implied by these statements. Össur hf. undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. All forward-looking statements are qualified in their entirety by this cautionary statement.